Frontlight ResearchEarly access
Trial site
The First Hospital of Qinhuangdao
- 5running trials
- 1closed trial
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Colorectal cancer1 trial
- COPD1 trial
- Metastatic breast cancer1 trial
- Obesity1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 33 trials
- Phase 2/31 trial
- Status
- Not yet recruiting3 trials
- Active, not recruiting2 trials
- Completed1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2 trials
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- Nanjing First Hospital, Nanjing Medical University1 trial
- Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.1 trial
- Zhuo Liu1 trial
Running trials
Not yet recruiting
Recruiting
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
Active, not recruiting
The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT)
Not yet recruiting
The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- COPD1 recruiting
- Metastatic breast cancer1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026